BetaShares Global Healthcare ETF - Currency Hedged (ASX:DRUG)
Australia flag Australia · Delayed Price · Currency is AUD
8.92
-0.03 (-0.34%)
At close: Jan 27, 2026

ASX:DRUG Holdings Information

ASX:DRUG is an equity ETF with a total of 82 individual holdings. The top holdings are Eli Lilly and Company stock at 7.90%, Johnson & Johnson at 7.38%, AbbVie at 5.40%, ROCHE HOLDING AG at 5.11%, and AstraZeneca at 4.73%.

Total Holdings
82
Top 10 Percentage
49.89%
Asset Class
Equity
ETF Category
Health Care
Assets
179.64M
PE Ratio
22.14

Sector Allocation

Top 25 Holdings

No.SymbolName WeightShares
1LLYEli Lilly and Company7.90%9,046
2JNJJohnson & Johnson7.38%42,057
3ABBVAbbVie Inc.5.40%30,852
4ROG.SEROCHE HOLDING AG5.11%14,266
5LON: AZNAstraZeneca PLC4.73%31,837
6NOVN.SENOVARTIS AG4.43%37,382
7UNHUnitedHealth Group Incorporated4.20%14,750
8MRKMerck & Co., Inc.3.78%43,077
9TMOThermo Fisher Scientific Inc.3.63%7,064
10NOVOB.DCNOVO NORDISK A/S3.36%66,543
11ABTAbbott Laboratories2.66%30,539
12AMGNAmgen Inc.2.63%9,457
13ISRGIntuitive Surgical, Inc.2.63%6,226
14DHRDanaher Corporation2.39%12,405
15GILDGilead Sciences, Inc.2.29%21,789
16PFEPfizer Inc.2.09%99,854
17SYKStryker Corporation1.96%6,795
18MDTMedtronic plc1.83%22,515
19BSXBoston Scientific Corporation1.77%24,197
20BMYBristol-Myers Squibb Company1.67%37,856
21EL.FPESSILORLUXOTTICA SA1.66%6,507
22SAN.FPSANOFI1.65%21,811
23LON: GSKGSK plc1.65%83,427
24VRTXVertex Pharmaceuticals Incorporated1.34%3,565
25ELVElevance Health, Inc.1.15%3,857
Showing 25 of 82 holdings
Subscribe to see the full list
As of Jan 23, 2026